Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | BPMC | NUVL | ||
| Company | Arena Pharmaceuticals | Blueprint Medicines Corp | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.97 | 99.33 | 94.41 | ||
| High | 100.00 | 102.46 | 96.40 | ||
| Low | 99.97 | 98.59 | 93.22 | ||
| Last | 99.99 | 101.39 | 94.09 | ||
| Change | +0.06 | +1.76 | unch | ||
| % Change | +0.06% | +1.77% | unch | ||
| Volume | 5,718,500 | 697,900 | 293,900 | ||
| 20-Day Average Volume | 1,676,465 | 711,645 | 460,860 | ||
| Previous Close | 99.93 | 99.63 | 94.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 88.70 | 96.14 | ||
| 20-Day Raw Stochastic | 99.86% | 95.07% | 35.87% | ||
| 20-Day Relative Strength | 75.07% | 66.44% | 49.10% | ||
| Weighted Alpha | -14.40 | +55.07 | +51.27 | ||
| Today's Opinion | 100% Buy | 8% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 8% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +15.86% since 10/31/24 | +6.33% since 10/31/24 | ||
| Low | 93.54 on 03/07/22 | 87.28 on 11/01/24 | 87.25 on 11/01/24 | ||
| High | 100.00 on 03/10/22 | 102.46 on 11/07/24 | 96.40 on 11/07/24 | ||
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | +13.51% since 10/07/24 | -8.98% since 10/07/24 | ||
| Low | 92.85 on 02/22/22 | 80.68 on 10/29/24 | 87.25 on 11/01/24 | ||
| High | 100.00 on 03/10/22 | 102.46 on 11/07/24 | 106.32 on 10/14/24 | ||
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | +11.60% since 08/07/24 | +39.52% since 08/07/24 | ||
| Low | 89.03 on 01/25/22 | 80.68 on 10/29/24 | 64.67 on 08/08/24 | ||
| High | 100.00 on 03/10/22 | 102.46 on 11/07/24 | 113.51 on 09/16/24 | ||
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | -6.60% since 05/07/24 | +37.08% since 05/07/24 | ||
| Low | 48.12 on 12/06/21 | 80.68 on 10/29/24 | 64.18 on 05/10/24 | ||
| High | 100.00 on 03/10/22 | 121.90 on 07/16/24 | 113.51 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 6,440,901 | 6,096,843 | ||
| Shares Outstanding, K | 61,659 | 63,526 | 64,798 | ||
| Annual Sales | 50,000 | 249,380,000 | 0 | ||
| Annual Net Income | -616,430,000 | -506,980,000 | -126,220,000 | ||
| Last Quarter Sales | 50,000 | 128,180,000 | 0 | ||
| Last Quarter Net Income | -155,610,000 | -56,280,000 | -57,170,000 | ||
| 60-Month Beta | 0.55 | 0.59 | 1.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | -0.89 on 10/30/24 | -0.88 on 08/08/24 | ||
| Latest Earnings Date | 05/04/22 | 10/30/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||